Earnings expectations have started to trend downward for companies with high exposure to Europe. » Read More
Mondelez has offered to buy Hershey for $107/share, and Hershey's board reportedly rejects the offer.
Mondelez has offered to buy Hershey for $107/share. A look at the challenges posed by this particular deal, with author Joel Glenn Brenner.
Mondelez offered to buy Hershey for $107/share. What that means to each stock, with Michael Lavery, CLSA, and Chad Morganlander, Washington Crossing Advisors.
CNBC's David Faber reports on months of discussion for Mondelez and Hershey before the offer was announced today.
CNBC's David Faber reports on Mondelez offer for Hershey, in which Mondelez is committed to keeping the Hershey name and moving its headquarters to Pennsylvania. The FMHR traders weigh in.
Morris Mark, Mark Asset Management President, discusses valuations in the market, and Mondelez's offer to Hershey.
Traders who bet big on the stock earlier this month are seeing huge profits on Thursday.
CNBC's David Faber reports Kit Kat's license would revert back to Nestle from Hershey on any deal between Mondelez and Hershey. Mondelez has offered to buy Hershey for $107 per share.
Sources say Mondelez offers to move its headquarters to Pennsylvania, and change its name to Hershey, reports CNBC's David Faber. Mondelez has offered to buy Hershey for $107 per share.
Hershey's stock has reopened for trading after reports Mondelez has made a bid for Hershey.
CNBC's David Faber has details of reports Mondelez has made a bid for Hershey.
U.S. stocks traded mostly higher, helped by gains in oil prices, with the Dow and S&P about 1 percent below their 52-week intraday highs.
Some of the names on the move ahead of the open.
Mondelez's mobile application has been such a success that the snack company plans to roll out similar games and move away from traditional ads.
Wall Street can be unkind, and Jim Cramer believes it’s missing the point in two retail stocks.
CNBC's Kate Kelly reports on the release of Pershing Square's 13F filing including a decreased stake in Air Products & Chemicals and Mondelez.
With the lack of sustained economic growth, companies have turned to buybacks and dividends to pick up the slack.
His Pershing Square Capital has had a difficult year, particularly over its stake in Valeant, the drug company that has come under intense scrutiny.
Mondelez Chairman and CEO Irene Rosenfeld discusses the company's better-than-expected revenue and profit.
Major food companies use downsizing as a tactic to hedge against increasing pressure to cut calories in processed foods, USA Today reports.